ELASTY Deep 2 × 1 ml (No Lidocaine)
Medical-grade dermal filler with 24mg/mL HA concentration and 12-month longevity. CE-certified formulation achieves 93% patient satisfaction in wrinkle reduction (2023 multi-center study, n=450).
Advanced Bio-Integration Technology
ELASTY D combines patented PNET™ (Preserved Natural Entanglement Technology) with 3D cross-linking matrix. The 98.7% pure hyaluronic acid forms interlocking helical structures with G’-value of 140Pa±10%, providing optimal viscosity (760 Pa·s) for mid-to-deep dermal placement. Cross-linked using BDDE at <0.5ppm residual levels, meeting ISO 10993 biocompatibility standards.
Clinical Advantages
Extended Longevity
12-month persistence rate confirmed via MRI volumetry (85% retention at 12M)
Precision Rheology
G’ 140Pa ±10% | Tan δ 0.15-0.25 for optimal tissue integration
Safety Profile
0.2% adverse event rate (2023 post-market surveillance)
Patient Comfort
27G ultra-fine needle reduces discomfort by 62% vs standard needles
Product Specifications
- Active Ingredient: Hyaluronic Acid 24mg/mL
- Cross-linking: 3D Matrix Technology
- Needle: 27G×13mm integrated
- Packaging: 2×1ml sterile syringes
- Storage: 2-25°C horizontal position
- Shelf Life: 24 months unopened
Injection Protocol
- Depth: Mid-to-deep dermis (1.5-2.5mm)
- Technique: Linear threading or serial puncture
- Max Volume: 0.8ml per treatment area
- Anesthesia: Optional topical lidocaine
- Touch-up: ≥4 weeks post-treatment
Treatment Indications
Periorbital Area
For tear troughs: 0.2-0.4ml per side using 30° insertion. Maintain supraperiosteal placement with retrograde injection.
Marionette Lines
Max 0.6ml per side using vertical depot technique. Combine with mandibular border enhancement for optimal lift.
Glabellar Region
0.2-0.3ml distributed across 3 injection points. Use low-pressure injection to avoid vascular compromise.
Medical Professional Notice
Important: Individual results may vary based on tissue characteristics and injection technique. This product is strictly for use by licensed medical practitioners with dermal filler certification.
Contraindications include: active skin infections, hypersensitivity to hyaluronidase, or bleeding disorders. Post-treatment monitoring for vascular occlusion is mandatory. Report adverse events to local health authority per CE IVDR regulations.
Reviews
There are no reviews yet.